A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)

NCT04624659 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Disease

Interventions

DRUG: Etavopivat Tablets Low dose
DRUG: Etavopivat Tablets High dose
DRUG: Placebo Tablets
DRUG: Etavopivat Tablets

Sponsor

Forma Therapeutics, Inc.

Collaborators

[object Object]